Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

NCT04905810 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
DRUG: Decitabine
DRUG: Venetoclax

Sponsor

Brian Jonas

Collaborators

[object Object]
[object Object]